Elliott G R, Tak C, Bonta I L
Department of Pharmacology, Medical Faculty, Erasmus University Rotterdam, The Netherlands.
Cancer Immunol Immunother. 1989;28(1):74-6. doi: 10.1007/BF00205804.
Human recombinant interleukin-1 (HrIL-1) inhibited WEHI-3B cell growth in a dose-related manner (10-10,000 U/ml). Prostaglandin E2 at high concentrations (1000 ng/ml) also inhibited cell growth. When added together, HrIL-1 and prostaglandin E2 inhibited WEHI-3B growth in a synergistic manner (HrIL-1 concentrations of 10-10,000 U/ml and prostaglandin E2 concentrations of 10-1000 ng/ml). In contrast to the effects of the cyclooxygenase metabolite of arachidonic acid leukotriene C4, a lipoxygenase metabolite, reversed the cytostatic action of HrIL-1.
人重组白细胞介素-1(HrIL-1)以剂量相关方式(10 - 10000 U/ml)抑制WEHI-3B细胞生长。高浓度(1000 ng/ml)的前列腺素E2也抑制细胞生长。当两者一起添加时,HrIL-1和前列腺素E2以协同方式抑制WEHI-3B生长(HrIL-1浓度为10 - 10000 U/ml,前列腺素E2浓度为10 - 1000 ng/ml)。与花生四烯酸的环氧化酶代谢产物的作用相反,脂氧合酶代谢产物白三烯C4逆转了HrIL-1的细胞生长抑制作用。